Clinical impact of thrombectomy in acute ST-elevation myocardial infarction: an individual patient-data pooled analysis of 11 trials

F Burzotta, M De Vita, YL Gu, T Isshiki… - European heart …, 2009 - academic.oup.com
Aims Thrombectomy in patients with ST-elevation myocardial infarction (STEMI) undergoing
percutaneous coronary intervention (PCI) is associated to better myocardial reperfusion …

[HTML][HTML] Drosophila neuroblasts sequentially express transcription factors which specify the temporal identity of their neuronal progeny

T Isshiki, B Pearson, S Holbrook, CQ Doe - Cell, 2001 - cell.com
Neural precursors often generate distinct cell types in a specific order, but the intrinsic or
extrinsic cues regulating the timing of cell fate specification are poorly understood. Here we …

An outbreak of VHSV (viral hemorrhagic septicemia virus) infection in farmed Japanese flounder Paralichthys olivaceus in Japan

T Isshiki, T Nishizawa, T Kobayashi, T Nagano… - Diseases of aquatic …, 2001 - int-res.com
A rhabdoviral disease occurred in farmed populations of market sized Japanese flounder
(hirame) Paralichthys olivaceus in the Seto Inland Sea of Japan in 1996. The causative …

Comparison of clopidogrel monotherapy after 1 to 2 months of dual antiplatelet therapy with 12 months of dual antiplatelet therapy in patients with acute coronary …

H Watanabe, T Morimoto, M Natsuaki… - JAMA …, 2022 - jamanetwork.com
Importance Clopidogrel monotherapy after short dual antiplatelet therapy (DAPT) after
percutaneous coronary intervention (PCI) has not yet been fully investigated in patients with …

Comparisons of baseline demographics, clinical presentation, and long-term outcome among patients with early, late, and very late stent thrombosis of sirolimus …

T Kimura, T Morimoto, K Kozuma, Y Honda, T Kume… - Circulation, 2010 - Am Heart Assoc
Background—Stent thrombosis (ST) after sirolimus-eluting stent implantation has not yet
been adequately characterized, mainly because of its low incidence. Methods and Results …

Therapeutic strategies targeting pro-fibrotic macrophages in interstitial lung disease

T Isshiki, M Vierhout, S Naiel, P Ali… - Biochemical …, 2023 - Elsevier
Idiopathic pulmonary fibrosis (IPF) is the representative phenotype of interstitial lung disease
where severe scarring develops in the lung interstitium. Although antifibrotic treatments are …

Efficacy and safety of adjusted-dose prasugrel compared with clopidogrel in Japanese patients with acute coronary syndrome–the PRASFIT-ACS study–

S Saito, T Isshiki, T Kimura, H Ogawa, H Yokoi… - Circulation …, 2014 - jstage.jst.go.jp
Background: Prasugrel is an antiplatelet agent that shows more prompt, potent, and
consistent platelet inhibition than clopidogrel. The objective of this study was to confirm the …

Therapeutic strategies to target connective tissue growth factor in fibrotic lung diseases

T Isshiki, S Naiel, M Vierhout, K Otsubo, P Ali… - Pharmacology & …, 2023 - Elsevier
The treatment of interstitial lung diseases, including idiopathic pulmonary fibrosis (IPF),
remains challenging as current available antifibrotic agents are not effective in halting …

Anatomic variations of the radial artery in patients undergoing transradial coronary intervention

N Yokoyama, S Takeshita, M Ochiai… - Catheterization and …, 2000 - Wiley Online Library
Anatomic variations of the radial artery and their effect on the use of the radial artery as a
route for transradial coronary intervention (TRI) were studied. Ultrasonography of the radial …

Prasugrel, a Third-Generation P2Y12 Receptor Antagonist, in Patients With Coronary Artery Disease Undergoing Elective Percutaneous Coronary Intervention–Phase …

T Isshiki, T Kimura, H Ogawa, H Yokoi, S Nanto… - Circulation …, 2014 - jstage.jst.go.jp
Background: Prasugrel is being developed in Japan as an antiplatelet therapy for use during
percutaneous coronary intervention (PCI). Up to 70% of Japanese patients with coronary …